NOVOSTE BETA-CATH SYSTEM
FDA premarket approval P000018/S024 · decided 2002-09-30
Approval details
- PMA number
- P000018
- Supplement
- S024
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- NOVOSTE BETA-CATH SYSTEM
- Generic name
- Intravascular radiation delivery system
- Applicant
- Best Vascular, Inc.
- Date received
- 2002-09-03
- Decision date
- 2002-09-30
- Days to decision
- 27 days
- Decision code
- OK30
- Product code
- MOU
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Norcross, GA
- Statement
- CHANGE IN THE MANUFACTURING PROCESS OF THE NOVOSTE BETA-CATH SYSTEM SOURCE TRAIN GOLD MARKERS WHICH INVOLVES THE REMOVAL OF THE ELECTROLESS NICKEL FLASHING PROCESS.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.